BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17898566)

  • 1. Progress in acute graft versus host disease.
    Holler E
    Curr Opin Hematol; 2007 Nov; 14(6):625-31. PubMed ID: 17898566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies.
    Zeiser R; Marks R; Bertz H; Finke J
    Ann Hematol; 2004 Sep; 83(9):551-65. PubMed ID: 15449032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of acute graft-versus-host disease.
    Bacigalupo A
    Br J Haematol; 2007 Apr; 137(2):87-98. PubMed ID: 17391488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for mesenchymal stem cells in the control of graft-versus-host disease.
    Cohen JL; Sudres M
    Transplantation; 2009 May; 87(9 Suppl):S53-4. PubMed ID: 19424007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the understanding of acute graft-versus-host disease.
    Morris ES; Hill GR
    Br J Haematol; 2007 Apr; 137(1):3-19. PubMed ID: 17359368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease.
    Sackstein R
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):2-8. PubMed ID: 16399577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Graft vs host disease].
    Moalic V; Ferec C
    Pathol Biol (Paris); 2006 May; 54(5):304-8. PubMed ID: 16530350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the management of acute graft-versus-host disease.
    Bolaños-Meade J
    Curr Opin Oncol; 2006 Mar; 18(2):120-5. PubMed ID: 16462179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathophysiology of acute graft-versus-host disease.
    Jaksch M; Mattsson J
    Scand J Immunol; 2005 May; 61(5):398-409. PubMed ID: 15882431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating graft-versus-host disease to enhance the graft-versus-leukemia effect.
    Alyea EP
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):239-50. PubMed ID: 18503989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic graft-versus-host disease.
    Cutler C; Antin JH
    Curr Opin Oncol; 2006 Mar; 18(2):126-31. PubMed ID: 16462180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute graft-versus-host disease.
    Bolaños-Meade J; Vogelsang GB
    Clin Adv Hematol Oncol; 2004 Oct; 2(10):672-82. PubMed ID: 16163254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
    Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer T cells and haemopoiesis.
    Karadimitris A; Patterson S; Spanoudakis E
    Br J Haematol; 2006 Aug; 134(3):263-72. PubMed ID: 16848769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Graft vs. host disease and graft vs. leukemia/tumor effect].
    Okamoto S
    Nihon Rinsho; 2003 Sep; 61(9):1484-7. PubMed ID: 14515713
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Duran-Struuck R; Reddy P
    Transplantation; 2008 Feb; 85(3):303-8. PubMed ID: 18301323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total lymphoid irradiation for graft-versus-host disease protection.
    Kohrt H; Lowsky R
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S23-6. PubMed ID: 19561409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
    Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
    Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation.
    Mohty M; Gaugler B
    Cytokine Growth Factor Rev; 2008 Feb; 19(1):53-63. PubMed ID: 18083060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.